Zumiez, Inc. (NASDAQ:ZUMZ) shares moved up 3.89% in last trading session and ended the day at $16.04. ZUMZ Gross Margin is 34.40% and its has a return on assets of 7.00%. Zumiez, Inc. (NASDAQ:ZUMZ) quarterly performance is 3.95%.
Zumiez Inc. (NASDAQ:ZUMZ) had its target price dropped by analysts at Susquehanna from $20.00 to $18.00 in a research note issued on Tuesday, Analyst Ratings.Net reports. The brokerage presently has a “positive” rating on the apparel and footwear maker’s stock. Susquehanna’s price objective suggests a potential upside of 22.62% from the stock’s current price.
AllianceBernstein Holding L.P. (NYSE:AB) ended the last trading day at $24.69. Company weekly volatility is calculated as 2.73%. AllianceBernstein Holding L.P. (NYSE:AB) showed a weekly performance of 3.18%.
MSC INDUSTRIAL SUPPLY CO. (NYSE: MSM), announced that the Company’s conference call to review its 2016 fiscal first quarter results, as well as its current operations, will be broadcast live over the Internet Wednesday, January 6, 2016 at 8:30 a.m. Eastern Time.
On 29 December, MSC Industrial Direct Co. Inc. (NYSE:MSM) shares moved up 0.49% and was closed at $57.44. MSM EPS growth in last 5 year was 9.60%. MSC Industrial Direct Co. Inc. (NYSE:MSM) year to date (YTD) performance is -27.63%.
Civitas Solutions, Inc. (NYSE:CIVI) shares moved up 0.50% in last trading session and ended the day at $29.94. CIVI Gross Margin is 22.50% and its has a return on assets of 0.30%. Civitas Solutions, Inc. (NYSE:CIVI) quarterly performance is 22.30%.
Civitas Solutions, Inc. (NYSE:CIVI) announced that it will conduct its 2016 annual meeting of stockholders on Friday, Friday 26, 2016 at 9:00 a.m. Eastern Time at its headquarters located at 313 Congress St., Boston, Massachusetts. The record date for determination of the Civitas stockholders entitled to notice of and to vote at the annual meeting is January 14, 2016 (the “Record Date”). The proxy statement containing additional meeting details and admission procedures is expected to be available no later than the last week of January to stockholders of record as of the Record Date.
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) caters to the Healthcare space. On the last day of trading company shares ended up at $1.26. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) distance from 50-day simple moving average (SMA50) is -26.01%.
On 21st December, AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) and EUSA Pharma, a newly-established specialty pharmaceutical business with global reach, announced an exclusive license agreement in which AVEO has granted EUSA Pharma European rights to tivozanib for the treatment of advanced renal cell carcinoma (“RCC”). The agreement also includes a number of additional territories outside North America, including South America and South Africa, and additional potential indications.
Leave a Reply